Cytotoxic Drugs Market: Rising Prevalence of Cancer Cases Coupled with Higher Access to Cancer Care in Emerging Markets Expected to Fuel Revenue Growth: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028

  • Published: 2018-10-16
  • Report Code: REP-GB-2515
  1. Home
  2. Syndicated Research

  3. Cytotoxic Drugs Market Analysis

An Incisive, In-depth Analysis on the Cytotoxic Drugs Market

This study offers a comprehensive, 360 degree analysis on the Cytotoxic Drugs market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Cytotoxic Drugs market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.

Request a sample
Ask An Analyst
Request Special Price
Request Methodology

Cytotoxic drugs are being used as a potent drug in cancer treatment. Cytotoxic drugs are also used in developing ADCs (antibody-drug conjugates): There are two types of cytotoxic agents available currently, one is DNA modifying agents and the other is microtubule disrupting agents which effects the cell cycle in order restrict them to multiply and unlike drugs of category which are cell life cycle specific, DNA modifying agents kill cells at any point.

Cytotoxic Drugs included in the report are products that are used for cancer treatment and research. The growth of the global Cytotoxic Drugs market is primarily driven by increasing prevalence of cancer indications, rising population prescribed with chemotherapy, awareness programs conducted by public and private associations, and other socio-economic factors. In terms of revenue, cytotoxic drugs segmented as antimetabolites are estimated dominated the global market in drug type category with over two third revenue share in recent years. 

Generic Cytotoxic Drugs industry is more accessible to new players given fragmented nature of the cytotoxic drug market in emerging economies. Generic version of cytotoxic drugs are more affordable and easily available among patient population in low income settings. Physicians in developed market however are opting for branded Cytotoxic Drugs due to positive outcomes in commercial usage. This boosts revenue generation for the leading manufacturers of branded cytotoxic drugs. Stringent regulations observed globally for cytotoxic drugs is a factor expected to hamper the revenue growth of the global Cytotoxic Drugs market over the forecast period.   

 

cytotoxic drugs market

 

In the drug type category for cytotoxic drugs, antimetabolites is the leading segment with most of the market share by value and volume. Others section is leading due to the inclusion of many types like metal salts, topoisomerase ii inhibitors, enzyme and more.

The global Cytotoxic Drugs market is estimated to expand at a CAGR of 0.9% over the forecast period of 2018 – 2028 to reach value of over US$ 17 Bn at the end of 2028. A significant drawback of the cytotoxic drugs market is manufacturers not filing for regulatory approval; delays or denials of approval; or, manufacturers awaiting the results of reimbursement negotiations prior to launching the drug in the country, etc. These factors cumulatively contribute towards cytotoxic drugs not being available in most of the countries or suffering critical shortage. Less than 20% of the entire gamut of cytotoxic drugs are available in most of the pharma emerging markets.

Geographically, the global Cytotoxic Drugs market is segmented into eight major regions, namely North America, Latin America, Western Europe, Eastern Europe, Asia Pacific (Asia-Pacific excluding China & Japan), China, Japan and Middle East & Africa (MEA). In terms of value, North America is expected to be the dominant regional market for Cytotoxic Drugs by 2018 end and is expected to expand at a healthy CAGR over the forecast period. Asia Pacific excluding China and Japan is expected to witness significant growth in the global Cytotoxic Drugs market over the forecast period. Europe is expected to grow in the global Cytotoxic Drugs market due to increasing demand for premium-priced products and favorable conditions for cancer care. Also, increasing number of specialty programs will lead to increased access to cytotoxic drugs. APECJ cytotoxic drugs market is estimated to reflect impressive growth due to expanding patient volume and price cutting. 

Examples of some of the key players operating in the Cytotoxic Drugs market include Sanofi, Pfizer, Novartis AG, Johnson and Johnson, F. Hoffmann-La Roche AG, Lonza, Celgene Corp., Amgen Inc. , GlaxoSmithKline PLC, Merck & Co., Inc., Eli Lilly and Company and Teva Pharmaceutical.

Cytotoxic Drugs is one of the most prominent segment for medications in cancer care. Technological advancements helps cytotoxic drugs market revenue to grow and to share the trend. Cytotoxic drugs are highly hazardous in nature. The growth of the cytotoxic drugs market is also related to the growing number of CDMOs, which play a vital role in the production of selective cytotoxic drugs. Manufacturing environment for cytotoxic drugs needs to be regulated, companies prefer to ask service from CDMOs and for the preparing combination drugs in larger amount. And with the increasing number of cancer cases, cytotoxic drugs will still find demand. It is expected to fuel the revenue growth of the cytotoxic drugs market. Furthermore, to understand the market correctly, the cytotoxic drugs market report is categorically split into three sections viz. market analysis by product type, by drug type, by route of administration, end users and regions.

The growth of the Cytotoxic Drugs market is dependent on various factors such as increased funding in cancer research, awareness campaigns by governments, etc. Similarly, manufacturing hazard associated with cytotoxic drugs makes it a rather open and diverse market for the manufacturers and potential distributors, with stable demand. The key players in the Cytotoxic Drugs market are particularly focusing on inorganic routes such as acquisitions, mergers, expansion, and adoption of new technologies in licensing.

The global cytotoxic drugs market has been segmented based on:

  • Product Type
  • Drug Type
  • Route Of Administration
  • End User
  • Region

The Cytotoxic Drugs report analyses the global Cytotoxic Drugs market in terms of value (US$). The Cytotoxic Drugs Market report begins with the market definition and overview explaining different market segments. Recent developments and major trends in the Cytotoxic Drugs market enable to identify the overall market scenario in various regions with the analysis of historical evolution of Cytotoxic Drugs in the market and possible future growth opportunities. The Cytotoxic Drugs market dynamics section includes company’s analyses on key trends, drivers, restraints, opportunities and macro factors influencing the global market. Impact analysis of key growth drivers and restraints of the Cytotoxic Drugs Market based on weighted average model has also been included in the report to better equip clients with crystal clear decision-making insights.

The report analyses the global Cytotoxic Drugs market based on the regions and presents the forecast in terms of value for the next 10 years. The regions covered in the report include:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APECJ
  • Japan
  • China
  • Middle East & Africa

The report analyses the global Cytotoxic Drugs market based on the product type and presents the forecast in terms of value for the next 10 years. The product types covered in the report include: 

  • Branded Drugs
  • Generic Drugs

The report analyses the global Cytotoxic Drugs market based on the drug type segment and presents the forecast in terms of value for the next 10 years. The drug type covered in the report include:  

  • Alkylating Agents
  • Antitumor Antibiotics 
  • Antimetabolites
  • Plant Alkaloids
  • Others

The report analyses the global Cytotoxic Drugs market based on the Route of Administration segment and presents the forecast in terms of value for the next 10 years. The Route of Administration covered in the report include:  

  • Oral
  • Parenteral

The report analyses the global Cytotoxic Drugs market based on the End User segment and presents the forecast in terms of value for the next 10 years. The End User covered in the report include:  

  • Hospital
  • Cancer Research Center
  • Drug Testing Laboratory
  • CDMOs

In addition, we have taken into consideration the year-on-year growth and incremental $ opportunity to understand the predictability of the market and to identify the right growth opportunities in the global Cytotoxic Drugs market.

Another key feature of this Cytotoxic Drugs report is the analysis of key segments in terms of market attractiveness index. This is the combination of market share index and CAGR of an individual segment and it provides the incremental opportunity of particular segment in the overall Cytotoxic Drugs market. This parameter is very critical for assessing the level of opportunity that a player in the Cytotoxic Drugs market can look to achieve, as well as to identify potential resources from the sales and delivery perspective of the products. The resulting index helps client to identify real market opportunities in Cytotoxic Drugs Market.

In the final section of the report on the global Cytotoxic Drugs market, the ‘Competitive Landscape’ is included to provide report audiences with a dashboard view, to access the key differentiators among the competitor firms. This section is primarily designed to provide clients with an objective and detailed comparative assessment of the key providers specific to Cytotoxic Drugs segment in the Cytotoxic Drugs market and participants across the value chain associated with cytotoxic drugs. Moreover, this section also includes market strategies and SWOT analysis of the major players in the global Cytotoxic Drugs market. 

Detailed profiles of the providers of Cytotoxic Drugs are also included in the scope of the report to evaluate their long- and short-term strategies. Examples of some of the key players in the global Cytotoxic Drugs market are Sanofi, Pfizer, Novartis AG, Johnson and Johnson, F. Hoffmann-La Roche AG, Lonza, Celgene Corp., Amgen Inc. , GlaxoSmithKline PLC, Merck & Co., Inc., Eli Lilly and Company and Teva Pharmaceutical.

Cytotoxic Drugs Market Reports - Table of Contents

Cytotoxic Drugs Market Reports - List of Tables

  1. Expenditure on Health, (% of GDP), by Country, 2016 - 2021

  2. Expenditure on Health, (% of GDP), by Country, 2016 - 2021

  3. Ongoing clinical trials for cytotoxic drugs 

  4. Cytotoxic Drugs in Markets Across The World

  5. Cytotoxic Agents and Specific Target

  6. North America Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country

  7. North America Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Drug Type

  8. North America Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Route Of Administration 

  9. North America Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Product Type

  10. North America Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User

  11. Latin America Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country 

  12. Latin America Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Drug Type

  13. Latin America Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Route Of Administration 

  14. Latin America Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Product Type

  15. Latin America Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User

  16. Western Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country

  17. Western Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Drug Type

  18. Western Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Route Of Administration 

  19. Western Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Product Type

  20. Western Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User

  21. Eastern Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country

  22. Eastern Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Drug Type

  23. Eastern Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Route Of Administration 

  24. Eastern Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Product Type

  25. Eastern Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User

  26. China Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Drug Type

  27. China Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Route Of Administration 

  28. China Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Product Type

  29. China Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User

  30. Japan Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Drug Type

  31. Japan Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Route Of Administration 

  32. Japan Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Product Type

  33. Japan Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User

  34. APECJ Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country

  35. APECJ Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Drug Type

  36. APECJ Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Route Of Administration 

  37. APECJ Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Product Type

  38. APECJ Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User

  39. MEA Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country

  40. MEA Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Drug Type

  41. MEA Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Route Of Administration 

  42. MEA Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Product Type

  43. MEA Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User

  44. Global Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Region

  45. Global Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Drug Type

  46. Global Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Route Of Administration

  47. Global Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Product Type

  48. Global Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By End User

Cytotoxic Drugs Market Reports - List of Figures

  1. Clinical trials of cytotoxics as reported, by Phase

  2. Number of clinical trials of cytotoxics, by Completion date ( 1993-2045)

  3. North America Cytotoxic Drugs Market Value Share by Drug Type, 2018

  4. North America Cytotoxic Drugs Market, BPS Analysis by Country – 2013, 2018 & 2028

  5. North America Cytotoxic Drugs Market Attractiveness Index by Country, 2018 – 2028

  6. North America Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017

  7. North America Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028

  8. North America Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By U.S.

  9. North America Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By U.S.

  10. North America Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Canada

  11. North America Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Canada

  12. North America Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Alkylating drugs

  13. North America Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Alkylating drugs

  14. North America Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Antimetabolites

  15. North America Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Antimetabolites

  16. North America Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, ByforPlant Alkaloids

  17. North America Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Plant Alkaloids

  18. North America Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Antitumor Antibiotics

  19. North America Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Antitumor Antibiotics

  20. North America Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Others

  21. North America Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2017–2028, By Others

  22. North America Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Oral

  23. North America Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Oral

  24. North America Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Parenteral 

  25. North America Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Parenteral

  26. North America Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Branded Drugs

  27. North America Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Branded Drugs

  28. North America Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Generic Drugs

  29. North America Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Generic Drugs

  30. North America Cytotoxic Drugs Market Attractiveness Analysis, By Drug Type

  31. North America Cytotoxic Drugs Market Attractiveness Analysis, By Route Of Administration 

  32. North America Cytotoxic Drugs Market Attractiveness Analysis, By Product Type

  33. North America Cytotoxic Drugs Market Attractiveness Analysis, By End User

  34. Latin America Cytotoxic Drugs Market Value Share by Drug Type, 2018

  35. Latin America Cytotoxic Drugs Market, BPS Analysis by Country – 2013, 2018 & 2028

  36. Latin America Cytotoxic Drugs Market Attractiveness Index by Country, 2018 – 2028

  37. Latin America Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017

  38. Latin America Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028

  39. Latin America Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Brazil

  40. Latin America Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Brazil

  41. Latin America Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Mexico

  42. Latin America Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Mexico

  43. Latin America Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Rest Of Latin America

  44. Latin America Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Rest Of Latin America

  45. Latin America Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Alkylating drugs

  46. Latin America Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Alkylating drugs

  47. Latin America Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Antimetabolites

  48. Latin America Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Antimetabolites

  49. Latin America Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Plant Alkaloids

  50. Latin America Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Plant Alkaloids

  51. Latin America Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Antitumor Antibiotics

  52. Latin America Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Antitumor Antibiotics

  53. Latin America Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Others

  54. Latin America Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2017–2028, By Others

  55. Latin America Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Oral

  56. Latin America Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Oral

  57. Latin America Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Parenteral 

  58. Latin America Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Parenteral

  59. Latin America Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Branded Drugs

  60. Latin America Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Branded Drugs

  61. Latin America Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Generic Drugs

  62. Latin America Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Generic Drugs

  63. Latin America Cytotoxic Drugs Market Attractiveness Analysis, By Drug Type

  64. Latin America Cytotoxic Drugs Market Attractiveness Analysis, By Route Of Administration 

  65. Latin America Cytotoxic Drugs Market Attractiveness Analysis, By Product Type

  66. Latin America Cytotoxic Drugs Market Attractiveness Analysis, By End User

  67. Western Europe Cytotoxic Drugs Market Value Share by Drug Type, 2018

  68. Western Europe Cytotoxic Drugs Market, BPS Analysis by Country – 2013, 2018 & 2028

  69. Western Europe Cytotoxic Drugs Market Attractiveness Index by Country, 2018 – 2028

  70. Western Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017

  71. Western Europe Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028

  72. Western Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Germany 

  73. Western Europe Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Germany 

  74. Western Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Spain

  75. Western Europe Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Spain

  76. Western Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Italy

  77. Western Europe Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Italy

  78. Western Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By U.K.

  79. Western Europe Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By U.K.

  80. Western Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By France

  81. Western Europe Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By France

  82. Western Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By NORDIC

  83. Western Europe Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By NORDIC

  84. Western Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By BENELUX

  85. Western Europe Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By BENELUX

  86. Western Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Rest of WE

  87. Western Europe Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Rest of WE

  88. Western Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Alkylating drugs

  89. Western Europe Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Alkylating drugs

  90. Western Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Antimetabolites

  91. Western Europe Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Antimetabolites

  92. Western Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Plant Alkaloids

  93. Western Europe Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Plant Alkaloids

  94. Western Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Antitumor Antibiotics

  95. Western Europe Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Antitumor Antibiotics

  96. Western Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Others

  97. Western Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2017–2028, By Others

  98. Western Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Oral

  99. Western Europe Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Oral

  100. Western Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Parenteral 

  101. Western Europe Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Parenteral

  102. Western Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Branded Drugs

  103. Western Europe Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Branded Drugs

  104. Western Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Generic Drugs

  105. Western Europe Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Generic Drugs

  106. Western Europe Cytotoxic Drugs Market Attractiveness Analysis, By Drug Type

  107. Western Europe Cytotoxic Drugs Market Attractiveness Analysis, By Route Of Administration 

  108. Western Europe Cytotoxic Drugs Market Attractiveness Analysis, By Product Type

  109. Western Europe Cytotoxic Drugs Market Attractiveness Analysis, By End User

  110. Eastern Europe Cytotoxic Drugs Market Value Share by Drug Type, 2018

  111. Eastern Europe Cytotoxic Drugs Market, BPS Analysis by Country – 2013, 2018 & 2028

  112. Eastern Europe Cytotoxic Drugs Market Attractiveness Index by Country, 2018 – 2028

  113. Eastern Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017

  114. Eastern Europe Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028

  115. Eastern Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Russia

  116. Eastern Europe Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Russia

  117. Eastern Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Poland

  118. Eastern Europe Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Poland

  119. Eastern Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Rest of EE

  120. Eastern Europe Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Rest of EE

  121. Eastern Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Alkylating drugs

  122. Eastern Europe Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Alkylating drugs

  123. Eastern Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Antimetabolites

  124. Eastern Europe Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Antimetabolites

  125. Eastern Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Plant Alkaloids

  126. Eastern Europe Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Plant Alkaloids

  127. Eastern Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Antitumor Antibiotics

  128. Eastern Europe Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Antitumor Antibiotics

  129. Eastern Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Others

  130. Eastern Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2017–2028, By Others

  131. Eastern Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Oral

  132. Eastern Europe Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Oral

  133. Eastern Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Parenteral 

  134. Eastern Europe Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Parenteral

  135. Eastern Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Branded Drugs

  136. Eastern Europe Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Branded Drugs

  137. Eastern Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Generic Drugs

  138. Eastern Europe Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Generic Drugs

  139. Eastern Europe Cytotoxic Drugs Market Attractiveness Analysis, By Drug Type

  140. Eastern Europe Cytotoxic Drugs Market Attractiveness Analysis, By Route Of Administration 

  141. Eastern Europe Cytotoxic Drugs Market Attractiveness Analysis, By Product Type

  142. Eastern Europe Cytotoxic Drugs Market Attractiveness Analysis, By End User

  143. China Cytotoxic Drugs Market Value Share by Drug Type, 2018

  144. China Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017

  145. China Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028

  146. China Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Alkylating drugs

  147. China Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Alkylating drugs

  148. China Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Antimetabolites

  149. China Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Antimetabolites

  150. China Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Plant Alkaloids

  151. China Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Plant Alkaloids

  152. China Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Antitumor Antibiotics

  153. China Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Antitumor Antibiotics

  154. China Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Others

  155. China Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2017–2028, By Others

  156. China Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Oral

  157. China Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Oral

  158. China Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Parenteral 

  159. China Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Parenteral

  160. China Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Branded Drugs

  161. China Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Branded Drugs

  162. China Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Generic Drugs

  163. China Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Generic Drugs

  164. China Cytotoxic Drugs Market Attractiveness Analysis, By Drug Type

  165. China Cytotoxic Drugs Market Attractiveness Analysis, By Route Of Administration 

  166. China Cytotoxic Drugs Market Attractiveness Analysis, By Product Type

  167. China Cytotoxic Drugs Market Attractiveness Analysis, By End User

  168. Japan Cytotoxic Drugs Market Value Share by Drug Type, 2018

  169. Japan Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017

  170. Japan Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028

  171. Japan Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Alkylating drugs

  172. Japan Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Alkylating drugs

  173. Japan Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Antimetabolites

  174. Japan Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Antimetabolites

  175. Japan Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Plant Alkaloids

  176. Japan Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Plant Alkaloids

  177. Japan Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Antitumor Antibiotics

  178. Japan Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Antitumor Antibiotics

  179. Japan Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Others

  180. Japan Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2017–2028, By Others

  181. Japan Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Oral

  182. Japan Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Oral

  183. Japan Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Parenteral 

  184. Japan Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Parenteral

  185. Japan Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Branded Drugs

  186. Japan Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Branded Drugs

  187. Japan Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Generic Drugs

  188. Japan Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Generic Drugs

  189. Japan Cytotoxic Drugs Market Attractiveness Analysis, By Drug Type

  190. Japan Cytotoxic Drugs Market Attractiveness Analysis, By Route Of Administration 

  191. Japan Cytotoxic Drugs Market Attractiveness Analysis, By Product Type

  192. Japan Cytotoxic Drugs Market Attractiveness Analysis, By End User

  193. APECJ Cytotoxic Drugs Market Value Share by Drug Type, 2018

  194. APECJ Cytotoxic Drugs Market, BPS Analysis by Country – 2013, 2018 & 2028

  195. APECJ Cytotoxic Drugs Market Attractiveness Index by Country, 2018 – 2028

  196. APECJ Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017

  197. APECJ Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028

  198. APECJ Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By India

  199. APECJ Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By India

  200. APECJ Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Australia and New Zealand

  201. APECJ Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Australia and New Zealand

  202. APECJ Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By ASEAN

  203. APECJ Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By ASEAN

  204. APECJ Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Rest of APECJ

  205. APECJ Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Rest of APECJ

  206. APECJ Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Alkylating drugs

  207. APECJ Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Alkylating drugs

  208. APECJ Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Antimetabolites

  209. APECJ Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Antimetabolites

  210. APECJ Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Plant Alkaloids

  211. APECJ Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Plant Alkaloids

  212. APECJ Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Antitumor Antibiotics

  213. APECJ Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Antitumor Antibiotics

  214. APECJ Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Others

  215. APECJ Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2017–2028, By Others

  216. APECJ Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Oral

  217. APECJ Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Oral

  218. APECJ Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Parenteral 

  219. APECJ Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Parenteral

  220. APECJ Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Branded Drugs

  221. APECJ Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Branded Drugs

  222. APECJ Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Generic Drugs

  223. APECJ Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Generic Drugs

  224. APECJ Cytotoxic Drugs Market Attractiveness Analysis, By Drug Type

  225. APECJ Cytotoxic Drugs Market Attractiveness Analysis, By Route Of Administration 

  226. APECJ Cytotoxic Drugs Market Attractiveness Analysis, By Product Type

  227. APECJ Cytotoxic Drugs Market Attractiveness Analysis, By End User

  228. MEA Cytotoxic Drugs Market Value Share by Drug Type, 2018

  229. MEA Cytotoxic Drugs Market, BPS Analysis by Country – 2013, 2018 & 2028

  230. MEA Cytotoxic Drugs Market Attractiveness Index by Country, 2018 – 2028

  231. MEA Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017

  232. MEA Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028

  233. MEA Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, ByGCC Countries

  234. MEA Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, ByGCC Countries

  235. MEA Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By South Africa

  236. MEA Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By South Africa

  237. MEA Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Rest of MEA

  238. MEA Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Rest of MEA

  239. MEA Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Alkylating drugs

  240. MEA Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Alkylating drugs

  241. MEA Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Antimetabolites

  242. MEA Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Antimetabolites

  243. MEA Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Plant Alkaloids

  244. MEA Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Plant Alkaloids

  245. MEA Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Antitumor Antibiotics

  246. MEA Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Antitumor Antibiotics

  247. MEA Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Others

  248. MEA Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2017–2028, By Others

  249. MEA Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Oral

  250. MEA Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Oral

  251. MEA Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Parenteral 

  252. MEA Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Parenteral

  253. MEA Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Branded Drugs

  254. MEA Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Branded Drugs

  255. MEA Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2017, By Generic Drugs

  256. MEA Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Generic Drugs

  257. MEA Cytotoxic Drugs Market Attractiveness Analysis, By Drug Type

  258. MEA Cytotoxic Drugs Market Attractiveness Analysis, By Route Of Administration 

  259. MEA Cytotoxic Drugs Market Attractiveness Analysis, By Product Type

  260. MEA Cytotoxic Drugs Market Attractiveness Analysis, By End User

  261. Global Cytotoxic Drugs Market Attractiveness Analysis, By Region

  262. Global Cytotoxic Drugs Market Analysis, byAlkylating drugs 

  263. Global Cytotoxic Drugs Market Analysis, by Antitumor Antibiotics 

  264. Global Cytotoxic Drugs Market Analysis, by Others 

  265. Global Cytotoxic Drugs Market Analysis, by Antimetabolites

  266. Global Cytotoxic Drugs Market Analysis, by Plant Alkaloids

  267. Global Cytotoxic Drugs Market Analysis, by Oral

  268. Global Cytotoxic Drugs Market Analysis, by Parenteral

  269. Global Cytotoxic Drugs Market Analysis, by 

  270. Global Cytotoxic Drugs Market Analysis, by Generic Drugs

  271. Global Cytotoxic Drugs Market Analysis, by Hospital

  272. Global Cytotoxic Drugs Market Analysis, by Cancer Research Center

  273. Global Cytotoxic Drugs Market Analysis, by Drug Testing Laboratory

  274. Global Cytotoxic Drugs Market Analysis, by CDMOs

  275. Global Cytotoxic Drugs Market Value Analysis and Forecast, 2017–2028 (US$ Mn)

  276. Global Cytotoxic Drugs Market Absolute $ Opportunity (US$ Mn), 2013–2017

  277. Global Cytotoxic Drugs Market Absolute $ Opportunity (US$ Mn), 2017–2028

  278. Global Cytotoxic Drugs Market Attractiveness Analysis, By Drug Type

  279. Global Cytotoxic Drugs Market Attractiveness Analysis, By Route Of Administration

  280. Global Cytotoxic Drugs Market Attractiveness Analysis, By Product Type

  281. Global Cytotoxic Drugs Market Attractiveness Analysis, By End User

Get in touch

Harish Tiwari

Harish Tiwari

Global Head - Business Development

+44 (0) 20 3287 4268
Pranay Mhaisekar

Pranay Mhaisekar

Business Development

+ 44 (0) 20 7692 8790
* indicates mandatory fields.

Latest Insights

Our Clients

Press Releases:

Recommendations

CASE STUDIES

See how our work makes an impact.

At FMI, we design strategies that are adaptive, impactful, and implementable.

Learn More
Request Sample Ask An Analyst Request Special Price Request Methodology